ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$15.30M	-
Other	Edwards Larry Todd	150.2K	$3.10M	-
Other	Matsuda Masaru	126.7K	$2.62M	-8,256
Other	Burnett Patrick	94.1K	$1.94M	-
Dir	Welgus Howard G.	69.7K	$1.44M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 20, 2025	Gilbert Halley E	Director	Sale+OE	16,532	$27.55	$455,441.72	-42.8%	-2.3%	-
Nov 19, 2025	Matsuda Masaru52	See Remarks	Sell	2,550	$28.29	$72,135.10	-0.8%	-4.6%	-
Nov 13, 2025	Krishnamohan Neha	Director	Sale+OE	40,504	$23.20	$939,493.81	-47.1%	+16.3%	-
Nov 6, 2025	Edwards Larry Todd	See Remarks	Sell	29,131	$25.16	$732,927.22	-16.2%	+3.9%	-
Nov 6, 2025	Burnett Patrick	See Remarks	Sale+OE	17,250	$24.18	$417,144.68	-14.9%	+3.9%	-
Nov 5, 2025	Burnett Patrick	See Remarks	Sell	6,486	$24.12	$156,449.49	-2.1%	+7.4%	-
Nov 3, 2025	Vairavan Latha	SVP Chief Financial Officer	Sell	88	$24.72	$2,175.23	-0.1%	+3.3%	-
Nov 3, 2025	Watanabe Todd66	See Remarks	Sell	11,547	$24.72	$285,399.17	-0.7%	+3.3%	-
Nov 3, 2025	Matsuda Masaru52	See Remarks	Sell	7,208	$24.72	$178,155.76	-2.3%	+3.3%	-
Nov 3, 2025	Welgus Howard G.62	Director	Sell	10,000	$25.27	$252,669.00	-10.0%	+3.3%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC